Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference

Rhea-AI Summary

Jazz Pharmaceuticals (Nasdaq: JAZZ) will participate in Citi's 2025 Global Healthcare Conference. Management will appear in a fireside chat on December 2, 2025 at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT. An audio webcast of the fireside chat will be available via the Investors section of Jazz Pharmaceuticals' website and a replay will be archived for 30 days.

Jazz Pharmaceuticals is a global biopharma focused on therapies for sleep disorders, epilepsy, and oncology, with R&D, manufacturing, and employees in multiple countries. For investor access, visit the company's investor events and presentations page.

DUBLIN, Nov. 18, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in Citi's 2025 Global Healthcare Conference. Company management will participate in a fireside chat on Tuesday, December 2, 2025, at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT.

An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be archived on the website for 30 days.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:
Investors:
Jack Spinks
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-citis-2025-global-healthcare-conference-302619149.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals (JAZZ) present at Citi's 2025 Global Healthcare Conference?

Jazz will present in a fireside chat on December 2, 2025 at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT.

How can investors listen to Jazz Pharmaceuticals' (JAZZ) Citi conference presentation on December 2, 2025?

An audio webcast will be available via the Investors section of the Jazz Pharmaceuticals website.

Will there be a replay of the Jazz Pharmaceuticals (JAZZ) fireside chat from Citi's 2025 Global Healthcare Conference?

Yes. A replay of the webcast will be archived on the company's website for 30 days.

Where is the Jazz Pharmaceuticals (JAZZ) investor webcast hosted for the Citi conference?

The webcast will be hosted on the Jazz Pharmaceuticals Investors » Events & Presentations page at investor.jazzpharma.com.

What topics will Jazz Pharmaceuticals (JAZZ) cover at Citi's 2025 Global Healthcare Conference?

The company announced a management fireside chat; no specific presentation topics or financial figures were disclosed in the announcement.